Tender Results of Nhs England

National Clinical Audit and Patient Outcome Programme (NCAPOP)-• Commission, develop and manage the NCAPOP on behalf of NHS England. • Manage up to 40 clinical audits and outcome review programmes • Design and tailor the outputs of the audits • Share outcomes data with NHS clinicians and professionals Possible extension, in multiple periods, of up to 24 months.

Service continuity for General Practices using Silicon Practice software-Silicon Practice is a supplier of general practice websites and online consultation systems. The company is in financial difficulty and administrators had recommended immediate cessation of software services to their general practice customers. This would have disrupted provision of general practice services to patients and would have had a detrimental effect on patient care. This business case is to cover costs of maintaining services to general practice for two weeks in order to enable a manag...

NHS National Generic Pharmaceuticals Wave 14a-NHS National Generic Pharmaceuticals Wave 14a: Potential periods of call-offs under the framework agreement: Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months) Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)

Cytosponge Evaluation Partner-Contract to a national Evaluator to comprehensively evaluate the Cytosponge programme. The requirements are; review impact, collate and interpret data and establishing processes.

The provision of Bi-Directional Interface with ESR_Cohort Portal-The overall aims and objectives are for the NHS to deliver a digital staff passport service to meet the needs of two main user cases: (a)the rotational movements of Doctors in Training (both permanent changes in employment and through lead employer arrangements) and; (b)temporary staff movements of any NHS staff member. This is a one-off requirement - no periodic review needed. NHS England and Improvement will provide the funding as outlined below to the supplier, to build the ESR-NH...

London Vanguard Independent Evaluation-The NHS Londons Violence Reduction Programme are seeking to appoint a suitable provider to carry out an independent evaluation of the London Vanguards. The London Vanguards are delivering a new model of care aimed at children and young people 0-25 years old who are impacted by violence. The model is being implemented across 3 Integrated Care Systems covering 13 London boroughs as a three year pilot until March 2025. Submitting a bid for this independent evaluation will be open to provid...

National Diabetes Prevention Programme FW3-NHS England will be seeking to appoint up to 5 providers to a new framework (Framework 3) to continue to deliver a behaviour change programme nationally, with the ability to offer face to face, digital (app web based) and remote (video/tele conferencing) service delivery. This new framework will also aim to: • Widen access and choice of prevention services, particularly for working age and younger cohorts, and individuals who experience health inequalities and inequity in access in commu...

CNO Safe Staffing Academic Partner-NHS England designed the CNO Safer Staffing Fellowship, a Masters Level workforce planning, delivery and assurance programme to support our vision of embedding a sustainable, consistent approach to safer staffing in our NHS in England. Following an Open OJEU tendering process NHS England has appointed Birmingham City University for this work. Ensuring evidence-based decision-making on safe and effective staffing is fundamental for all NHS organisations. Strong support to Trusts and Executi...

NHS North of England Branded Medicines Tranche A & Annual Tranche-NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche. Offer reference number: CM/PHR/20/5606 CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of fram...

NHS National Generics Pharmaceuticals Transition 2023_1-Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (...